Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2021-11-08 00:00:00 ET · period of report 2021-11-04 · accession 0001819790-21-000047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-08 | 2021-11-04+ | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $28.04 | -111 | 52.1K | -0.2% | -$3,112 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-04 | S | D | 100 | $28.03 | 52,103 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-05 | S | D | 11 | $28.11 | 52,092 | D | — | — |